- Home
- CCLD vs ADAP Comparison
CCLD vs ADAP Comparison
Compare CCLD & ADAP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CCLD
- ADAP
- Stock Information
- Founded
- CCLD 1999
- ADAP 2008
- Country
- CCLD United States
- ADAP United Kingdom
- Employees
- CCLD N/A
- ADAP N/A
- Industry
- CCLD Computer Software: Prepackaged Software
- ADAP Biotechnology: Pharmaceutical Preparations
- Sector
- CCLD Technology
- ADAP Health Care
- Exchange
- CCLD Nasdaq
- ADAP Nasdaq
- Market Cap
- CCLD 87.2M
- ADAP 75.5M
- IPO Year
- CCLD 2014
- ADAP 2015
- Fundamental
- Price
- CCLD $2.50
- ADAP $0.25
- Analyst Decision
- CCLD Buy
- ADAP Buy
- Analyst Count
- CCLD 2
- ADAP 6
- Target Price
- CCLD $3.00
- ADAP $1.52
- AVG Volume (30 Days)
- CCLD 411.9K
- ADAP 583.7K
- Earning Date
- CCLD 08-12-2025
- ADAP 08-11-2025
- Dividend Yield
- CCLD N/A
- ADAP N/A
- EPS Growth
- CCLD N/A
- ADAP N/A
- EPS
- CCLD N/A
- ADAP N/A
- Revenue
- CCLD $112,507,000.00
- ADAP $179,639,000.00
- Revenue This Year
- CCLD $2.74
- ADAP N/A
- Revenue Next Year
- CCLD $7.52
- ADAP $35.48
- P/E Ratio
- CCLD N/A
- ADAP N/A
- Revenue Growth
- CCLD N/A
- ADAP 878.53
- 52 Week Low
- CCLD $1.14
- ADAP $0.20
- 52 Week High
- CCLD $4.84
- ADAP $1.48
- Technical
- Relative Strength Index (RSI)
- CCLD 68.67
- ADAP 42.09
- Support Level
- CCLD $2.05
- ADAP $0.24
- Resistance Level
- CCLD $2.56
- ADAP $0.27
- Average True Range (ATR)
- CCLD 0.14
- ADAP 0.02
- MACD
- CCLD 0.03
- ADAP -0.00
- Stochastic Oscillator
- CCLD 89.66
- ADAP 23.57
About CCLD CareCloud Inc.
CareCloud Inc is a healthcare information technology company. The company provides a full suite of proprietary cloud-based solutions and related business services. Its Software-as-a-Service platforms include practice management (PM), electronic health record (EHR), business intelligence, patient experience management (PXM) solutions, and robotic processing automation (RPA) bots, along with complementary software tools and business services such as revenue cycle management (RCM), premiere healthcare consulting and implementation services, and on-demand workforce staffing capabilities for high-performance medical groups and health systems nationwide. The operating segments of the group are Healthcare IT, which is the key revenue-generating segment, and Medical Practice Management.
About ADAP Adaptimmune Therapeutics plc
Adaptimmune Therapeutics PLC is a commercial-stage biopharmaceutical company working to redefine the treatment of solid tumor cancers with cell therapies. It has developed a comprehensive proprietary platform that enables it to identify cancer targets, find and genetically engineer T-cell receptors, and produce TCR therapeutic candidates for administration to patients. Its programs include MAGE-A4 SPEAR T-cell therapy, NY-ESO SPEAR T-cell, CD70, and others for multiple cancer types.